Jump to content
  • Sign Up

PhytoTech Medical Limited (ASX:PYL) Yissum Licensing Agreement Amendme


Recommended Posts

"The Company is focused on the research, development and commercialization of products for administering MGC, and on new treatments utilizing MGC therapeutic components for various medical conditions. In addition, the Company aims to grow proprietary strains of MGC in California, Uruguay and other jurisdictions."

 

There's only one thing this company is focused on ?! MONEY, money,money,money. First they tried in tassie, then tried to setup grow @ norfolk Is and sell to OS . Now the research goes into pills! So we can end up buyin some outragesly overpriced THC/CBD pills from a pharmacy. lol

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using the community in any way you agree to our Terms of Use and We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.